Castonguay, M.; Roy, J.; Claveau, J.-S.; Lachance, S.; Delisle, J.-S.; Kiss, T.; Cohen, S.; Fleury, I.; Mollica, L.; Ahmad, I.;
et al. Allogeneic Hematopoietic Cell Transplant for B-Cell Lymphomas in the Era of Novel Cellular Therapies: Experience from a Tertiary Canadian Center. Curr. Oncol. 2025, 32, 285.
https://doi.org/10.3390/curroncol32050285
AMA Style
Castonguay M, Roy J, Claveau J-S, Lachance S, Delisle J-S, Kiss T, Cohen S, Fleury I, Mollica L, Ahmad I,
et al. Allogeneic Hematopoietic Cell Transplant for B-Cell Lymphomas in the Era of Novel Cellular Therapies: Experience from a Tertiary Canadian Center. Current Oncology. 2025; 32(5):285.
https://doi.org/10.3390/curroncol32050285
Chicago/Turabian Style
Castonguay, Mathias, Jean Roy, Jean-Sébastien Claveau, Sylvie Lachance, Jean-Sébastien Delisle, Thomas Kiss, Sandra Cohen, Isabelle Fleury, Luigina Mollica, Imran Ahmad,
and et al. 2025. "Allogeneic Hematopoietic Cell Transplant for B-Cell Lymphomas in the Era of Novel Cellular Therapies: Experience from a Tertiary Canadian Center" Current Oncology 32, no. 5: 285.
https://doi.org/10.3390/curroncol32050285
APA Style
Castonguay, M., Roy, J., Claveau, J.-S., Lachance, S., Delisle, J.-S., Kiss, T., Cohen, S., Fleury, I., Mollica, L., Ahmad, I., Bambace, N., Bernard, L., Roy, D.-C., Sauvageau, G., & Veilleux, O.
(2025). Allogeneic Hematopoietic Cell Transplant for B-Cell Lymphomas in the Era of Novel Cellular Therapies: Experience from a Tertiary Canadian Center. Current Oncology, 32(5), 285.
https://doi.org/10.3390/curroncol32050285
